Insmed (INSM) Receives a Buy From Morgan Stanley
Insmed Analyst Ratings
Insmed's Promising Outlook: Buy Rating Backed by Arikayce Performance and Brenso Launch Potential
Strong Arikayce Sales and Promising Clinical Advancements Bolster Buy Rating for Insmed
Analysts Offer Insights on Industrial Goods Companies: Rockwell Automation (ROK), FTAI Aviation (FTAI) and AerSale Corporation (ASLE)
Buy Rating Affirmed for HealthEquity on Strategic Alignment and Innovation Investments
Morgan Stanley Lowers Price Target on Abercrombie & Fitch to $155 From $172, Keeps Equalweight Rating
Buy Rating Affirmed for Vaxcyte Ahead of Key VAX-31 Phase 1/2 Milestone
Vaxcyte Analyst Ratings
TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating
Optimistic Buy Rating for Vaxcyte Amidst Promising Vaccine Candidate Progress and Strategic Positioning
Ensign Energy Services (ESI) Gets a Hold From CIBC
SPS Commerce Price Target Maintained With a $230.00/Share by Needham
SPS Commerce Analyst Ratings
William Blair Maintains SPS Commerce(SPSC.US) With Hold Rating
Needham Maintains SPS Commerce(SPSC.US) With Buy Rating, Raises Target Price to $230
Buy Rating Affirmed: SPS Commerce's Strategic Acquisition of SupplyPike Promises Growth and Market Expansion
Ensign Group Analyst Ratings
Truist Financial Maintains Ensign(ENSG.US) With Hold Rating, Announces Target Price $160
Jefferies Maintains Sprouts Farmers Market(SFM.US) With Hold Rating, Raises Target Price to $96